White label ELPA - ClinicalTrials.eu

Study to Compare Weekly Islatravir/Lenacapavir with Bictegravir/Emtricitabine/Tenofovir in People with HIV-1 Who Are Virologically Suppressed

Not recruiting

3 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

Not recruiting

4 1 1

+2
Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
Study on the Effects of Mosliciguat for Patients with Pulmonary Hypertension Linked to Interstitial Lung Disease

Not recruiting

2 1
Investigated Diseases:
- Pulmonary hypertension
Investigated Drugs:
- Mosliciguat
+3
Study on [18F]Fluoro-PEG-Folate PET Scans for Identifying Rheumatoid Arthritis Risk in Individuals with ACPA Positive Arthralgia

Not recruiting

2 1 1
Investigated Drugs:
- [18F]Fluoro-Peg-Folate
Study on Rituximab for Reducing Steroid Use in Newly Diagnosed Polymyalgia Rheumatica Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Polymyalgia rheumatica
Investigated Drugs:
- Rituximab
Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Pancreatic carcinoma
Investigated Drugs:
+3
Study of Pembrolizumab and Lenvatinib for Patients with Classic Kaposi Sarcoma After Previous Treatment

Not recruiting

2 1 1 1
Investigated Diseases:
- Kaposi’s sarcoma
Investigated Drugs:
- Lenvatinib
- Pembrolizumab
Study on the Use of Empagliflozin for Treating Neutropenia in Patients with Glycogen Storage Disease Type Ib

Not recruiting

2 1 1 1
Investigated Diseases:
- Neutropenia
Investigated Drugs:
- Empagliflozin

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies